Quick Answer
SeaStar Medical Holding Corp reported Research And Development Expense of $7.52 million for the year ending 2025.
- SeaStar Medical Holding Corp showed a decrease of -17.4% in Research And Development Expense from 2024 to 2025.
- This data is from SeaStar Medical Holding Corp's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), SeaStar Medical Holding Corp's Research And Development Expense has grown by 171.8%.
- Historical annual values: Fiscal year 2025: $7.52 million | Fiscal year 2024: $9.11 million | Fiscal year 2023: $5.97 million | Fiscal year 2022: $2.50 million | Fiscal year 2021: $2.77 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: